Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€232.25

€232.25

-0.430%
-1.0
-0.430%
€336.78

€336.78

 
23.12.25 / Tradegate WKN: A2PA9L / Symbol: CI / Name: Cigna / Stock / Healthcare Providers & Services / Large Cap /
Latest predictions
15:01
-
buy
€269.48
11.12.25
0.63%
buy
05.12.25
1.55%
buy
02.12.25
-1.17%
buy
€260.18
08.11.25
1.29%
buy
€289.34
04.11.25
1.71%
buy
Your prediction

Cigna Corp. Stock

The price for the Cigna Corp. stock decreased slightly today. Compared to yesterday there is a change of -€1.000 (-0.430%).
With 43 Buy predictions and not a single Sell prediction Cigna Corp. is an absolute favorite of our community.
As a result the target price of 336 € shows a positive potential of 44.67% compared to the current price of 232.25 € for Cigna Corp..

Pros and Cons of Cigna Corp. in the next few years

Pros
?
S********** s********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

Cigna Group (NYSE:CI) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Ratings data for CI provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 0.63%
Target price 269.483
Change
Ends at 11.12.26

Cigna Group (NYSE:CI) had its price target lowered by analysts at Robert W. Baird from $372.00 to $315.00. They now have an "outperform" rating on the stock.
Ratings data for CI provided by MarketBeat
Show more

Cigna Group (NYSE:CI) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Ratings data for CI provided by MarketBeat
Show more

News

Cigna (CI) Q2 Revenue Jumps 11%
Cigna (CI) Q2 Revenue Jumps 11%

Cigna Group (NYSE:CI), a global health services company offering integrated medical, pharmacy, and specialty care solutions, released its second-quarter earnings on July 31, 2025. The company